Advanced Solid Tumor
Showing NaN - NaN of 34
Advanced Solid Tumor Trial in United States (CLN-617, Pembrolizumab)
Not yet recruiting
- Advanced Solid Tumor
-
Los Angeles, California
- +5 more
Sep 12, 2023
Advanced Solid Tumor, Hepatocellular Carcinoma Trial in Los Angeles (TORL-4-500)
Not yet recruiting
- Advanced Solid Tumor
- Hepatocellular Carcinoma
-
Los Angeles, CaliforniaUCLA - JCCC Clinical Research Unit
Aug 23, 2023
Advanced Solid Tumor, Colorectal Cancer Trial in Los Angeles (TORL-3-600)
Not yet recruiting
- Advanced Solid Tumor
- Colorectal Cancer
-
Los Angeles, CaliforniaUCLA - JCCC Clinical Research Unit
Jul 20, 2023
Advanced Solid Tumor, Castration-Resistant Prostatic Cancer, Malignant Melanoma Trial in United States (MGC018, lorigerlimab)
Recruiting
- Advanced Solid Tumor
- +6 more
- vobramitamab duocarmazine
- lorigerlimab
-
Los Angeles, California
- +7 more
Jan 10, 2023
Advanced Solid Tumor, Malignant Solid Tumor Trial in Japan, United States (DS-7300a)
Recruiting
- Advanced Solid Tumor
- Malignant Solid Tumor
-
Los Angeles, California
- +21 more
Jan 5, 2023
Advanced Solid Tumor Trial in Spain, United Kingdom, United States (AFM24, Atezolizumab 840 MG in 14 ML Injection)
Recruiting
- Advanced Solid Tumor
- AFM24
- Atezolizumab 840 MG in 14 ML Injection
-
Los Angeles, California
- +5 more
Dec 5, 2022
Advanced Solid Tumor, Advanced/ Metastatic Renal Cell Carcinoma (RCC), Microsatellite Iinstability-high (MSI-H) or Mismatch
Active, not recruiting
- Advanced Solid Tumor
- +3 more
- TP-1454 monotherapy
- TP-1454 combination therapy
-
Phoenix, Arizona
- +8 more
Nov 18, 2022
KRAS Mutation-Related Tumors, Metastatic Solid Tumor, Advanced Solid Tumor Trial in United States (TPX-0005, Trametinib)
Active, not recruiting
- KRAS Mutation-Related Tumors
- +2 more
-
Los Angeles, California
- +5 more
Nov 7, 2022
Advanced Solid Tumor Trial in United States (Part 1 ES002023, Part 2 ES002023)
Active, not recruiting
- Advanced Solid Tumor
- Part 1 ES002023
- Part 2 ES002023
-
Scottsdale, Arizona
- +6 more
Oct 18, 2022
Advanced Solid Tumor, Clear Cell Renal Cell Carcinoma, Hepatocellular Carcinoma Trial in Korea, Republic of, Singapore, United
Recruiting
- Advanced Solid Tumor
- +3 more
-
Duarte, California
- +22 more
Aug 17, 2022
Solid Tumor, Adult, Advanced Solid Tumor, Metastatic Solid Tumor Trial in United Kingdom, United States (Etigilimab dosing,
Recruiting
- Solid Tumor, Adult
- +2 more
- Etigilimab dosing
- Nivolumab
-
Phoenix, Arizona
- +15 more
Jun 6, 2022
Advanced Solid Tumor Trial in United States (AGEN1223, AGEN1223 and balstilimab)
Terminated
- Advanced Solid Tumor
- AGEN1223
- AGEN1223 and balstilimab
-
Scottsdale, Arizona
- +3 more
Feb 15, 2022